No Data
No Data
No Data
No Data
No Data
Opyl Ltd. Calls for Virtual General Meeting
TipRanks23:57 ET
Opyl Expands TrialKey Coverage; Shares Up 38%
Digital health company Opyl (ASX:OPL) expanded its TrialKey.ai platform, increasing its coverage to 350,000 trials from 65,000 and enhancing its ability to predict and optimize clinical research and d
MT Newswires21:40 ET
Opyl to Divest Opin Business
Opyl (ASX:OPL) signed a binding sale and purchase agreement to divest its Opin business, allowing the company to focus on high-growth, artificial intelligence-related ventures, according to a Tuesday
MT NewswiresApr 22 22:36 ET
Opyl Divests Subsidiary Opin to Focus on Development of AI Clinical Trial Platform
Opyl (ASX: OPL) will divest its clinical trial recruitment subsidiary Opin to an entity controlled by global health technology entrepreneur Dr Hugo Stephenson.
Small CapsApr 22 21:51 ET
Opyl Receives Offer for Patient Recruitment Business
Opyl (ASX:OPL) received a non-binding offer to acquire its patient candidate recruitment business, Opin, from Trial Screen for AU$1 and 20% of the equity in Trial Screen. Trial Screen is an entity con
MT NewswiresMar 22 03:29 ET
Opyl Requests Trading Halt After Receiving Offer For Opin Business
Opyl (ASX:OPL) requested a halt in the trading of its securities Wednesday afternoon after receiving a non-binding offer to acquire the company's Opin business, according to a same-day filing with the
MT NewswiresMar 20 04:33 ET
No Data
No Data